{"id":"https://openalex.org/W3014291483","doi":"https://doi.org/10.1016/j.bulcan.2020.02.010","title":"Place des anticoagulants oraux directs dans la prise en charge de la maladie thromboembolique veineuse associ\u00e9e au cancer en 2020","display_name":"Place des anticoagulants oraux directs dans la prise en charge de la maladie thromboembolique veineuse associ\u00e9e au cancer en 2020","alternate_titles":[],"publication_year":2020,"publication_date":"2020-04-03","ids":{"openalex":"https://openalex.org/W3014291483","doi":"https://doi.org/10.1016/j.bulcan.2020.02.010","mag":"3014291483","pmid":"https://pubmed.ncbi.nlm.nih.gov/32252973"},"language":"fr","primary_location":{"id":"doi:10.1016/j.bulcan.2020.02.010","doi":"https://doi.org/10.1016/j.bulcan.2020.02.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bulcan.2020.02.010","pdf_url":"https://www.sciencedirect.com/science/article/am/pii/S0007455120301466","source":{"id":"https://openalex.org/S22998730","display_name":"Bulletin du Cancer","issn_l":"0007-4551","issn":["0007-4551","1769-6917"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Bulletin du Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3014291483"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/am/pii/S0007455120301466","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013814216","display_name":"Claire Auditeau","orcid":"https://orcid.org/0000-0002-8499-1862","observed_orcids":["https://orcid.org/0000-0002-8499-1862"]},"institutions":[{"id":"https://openalex.org/I1288880153","display_name":"H\u00f4pital Necker-Enfants Malades","ror":"https://ror.org/05tr67282","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I1288880153","https://openalex.org/I4210097159","https://openalex.org/I4210120235"]},{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4405261462","display_name":"Laboratoire d'h\u00e9matologie","ror":"https://ror.org/05b9w4n89","country_code":"FR","type":"facility","lineage":["https://openalex.org/I204730241","https://openalex.org/I4210097159","https://openalex.org/I4405261462"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Claire Auditeau","raw_affiliation_strings":["AP-HP, universit\u00e9 de Paris, H\u00f4pital Necker-Enfants Malades, laboratoire d'h\u00e9matologie, Paris, France","H\u00f4pital Necker - Enfants Malades [AP-HP]","Universit\u00e9 Paris Cit\u00e9"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AP-HP, universit\u00e9 de Paris, H\u00f4pital Necker-Enfants Malades, laboratoire d'h\u00e9matologie, Paris, France","institution_ids":["https://openalex.org/I1288880153","https://openalex.org/I204730241","https://openalex.org/I4210097159","https://openalex.org/I4405261462"]},{"raw_affiliation_string":"H\u00f4pital Necker - Enfants Malades [AP-HP]","institution_ids":["https://openalex.org/I1288880153","https://openalex.org/I4210097159"]},{"raw_affiliation_string":"Universit\u00e9 Paris Cit\u00e9","institution_ids":["https://openalex.org/I204730241"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064211339","display_name":"Alexis Talbot","orcid":"https://orcid.org/0000-0001-6734-413X","observed_orcids":["https://orcid.org/0000-0001-6734-413X"]},"institutions":[{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]},{"id":"https://openalex.org/I4405261462","display_name":"Laboratoire d'h\u00e9matologie","ror":"https://ror.org/05b9w4n89","country_code":"FR","type":"facility","lineage":["https://openalex.org/I204730241","https://openalex.org/I4210097159","https://openalex.org/I4405261462"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Alexis Talbot","raw_affiliation_strings":["AP-HP, universit\u00e9 de Paris, H\u00f4pital Saint-Louis, service d'immuno-h\u00e9matologie clinique, 75010 Paris, France","Hopital Saint-Louis [AP-HP]","Universit\u00e9 Paris Cit\u00e9"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AP-HP, universit\u00e9 de Paris, H\u00f4pital Saint-Louis, service d'immuno-h\u00e9matologie clinique, 75010 Paris, France","institution_ids":["https://openalex.org/I204730241","https://openalex.org/I4210097159","https://openalex.org/I4210144610","https://openalex.org/I4405261462"]},{"raw_affiliation_string":"Hopital Saint-Louis [AP-HP]","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]},{"raw_affiliation_string":"Universit\u00e9 Paris Cit\u00e9","institution_ids":["https://openalex.org/I204730241"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049751911","display_name":"Adeline Blandini\u00e8res","orcid":"https://orcid.org/0000-0001-5285-9165","observed_orcids":["https://orcid.org/0000-0001-5285-9165"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4210102325","display_name":"H\u00f4pital Europ\u00e9en Georges-Pompidou","ror":"https://ror.org/016vx5156","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210102325","https://openalex.org/I4210120235"]},{"id":"https://openalex.org/I4387152685","display_name":"Innovations Th\u00e9rapeutiques en H\u00e9mostase","ror":"https://ror.org/02jp0cd74","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4387152685"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Adeline Blandini\u00e8res","raw_affiliation_strings":["Universit\u00e9 de Paris, Innovative Therapies in Haemostasis, Inserm, 75006 Paris, France; AH-HP, H\u00f4pital europ\u00e9en Georges Pompidou, service d'h\u00e9matologie biologique et laboratoire de recherches biochirurgicales (fondation Carpentier), 75015 Paris, France","H\u00f4pital Europ\u00e9en Georges Pompidou [APHP]","Innovations th\u00e9rapeutiques en h\u00e9mostase = Innovative Therapies in Haemostasis","Universit\u00e9 Paris Cit\u00e9"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 de Paris, Innovative Therapies in Haemostasis, Inserm, 75006 Paris, France; AH-HP, H\u00f4pital europ\u00e9en Georges Pompidou, service d'h\u00e9matologie biologique et laboratoire de recherches biochirurgicales (fondation Carpentier), 75015 Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210102325","https://openalex.org/I4387152685"]},{"raw_affiliation_string":"H\u00f4pital Europ\u00e9en Georges Pompidou [APHP]","institution_ids":["https://openalex.org/I4210102325"]},{"raw_affiliation_string":"Innovations th\u00e9rapeutiques en h\u00e9mostase = Innovative Therapies in Haemostasis","institution_ids":["https://openalex.org/I4387152685"]},{"raw_affiliation_string":"Universit\u00e9 Paris Cit\u00e9","institution_ids":["https://openalex.org/I204730241"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015477632","display_name":"David M. Smadja","orcid":"https://orcid.org/0000-0001-7731-9202","observed_orcids":["https://orcid.org/0000-0001-7731-9202"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4210102325","display_name":"H\u00f4pital Europ\u00e9en Georges-Pompidou","ror":"https://ror.org/016vx5156","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210102325","https://openalex.org/I4210120235"]},{"id":"https://openalex.org/I4387152685","display_name":"Innovations Th\u00e9rapeutiques en H\u00e9mostase","ror":"https://ror.org/02jp0cd74","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4387152685"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"David M. Smadja","raw_affiliation_strings":["Universit\u00e9 de Paris, Innovative Therapies in Haemostasis, Inserm, 75006 Paris, France; AH-HP, H\u00f4pital europ\u00e9en Georges Pompidou, service d'h\u00e9matologie biologique et laboratoire de recherches biochirurgicales (fondation Carpentier), 75015 Paris, France","H\u00f4pital Europ\u00e9en Georges Pompidou [APHP]","Innovations th\u00e9rapeutiques en h\u00e9mostase = Innovative Therapies in Haemostasis","Universit\u00e9 Paris Cit\u00e9"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 de Paris, Innovative Therapies in Haemostasis, Inserm, 75006 Paris, France; AH-HP, H\u00f4pital europ\u00e9en Georges Pompidou, service d'h\u00e9matologie biologique et laboratoire de recherches biochirurgicales (fondation Carpentier), 75015 Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210102325","https://openalex.org/I4387152685"]},{"raw_affiliation_string":"H\u00f4pital Europ\u00e9en Georges Pompidou [APHP]","institution_ids":["https://openalex.org/I4210102325"]},{"raw_affiliation_string":"Innovations th\u00e9rapeutiques en h\u00e9mostase = Innovative Therapies in Haemostasis","institution_ids":["https://openalex.org/I4387152685"]},{"raw_affiliation_string":"Universit\u00e9 Paris Cit\u00e9","institution_ids":["https://openalex.org/I204730241"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5136608968","display_name":"Nicolas Gendron","orcid":"https://orcid.org/0000-0003-4852-4738","observed_orcids":["https://orcid.org/0000-0003-4852-4738"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4210102325","display_name":"H\u00f4pital Europ\u00e9en Georges-Pompidou","ror":"https://ror.org/016vx5156","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210102325","https://openalex.org/I4210120235"]},{"id":"https://openalex.org/I4387152685","display_name":"Innovations Th\u00e9rapeutiques en H\u00e9mostase","ror":"https://ror.org/02jp0cd74","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4387152685"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Nicolas Gendron","raw_affiliation_strings":["Universit\u00e9 de Paris, Innovative Therapies in Haemostasis, Inserm, 75006 Paris, France; AH-HP, H\u00f4pital europ\u00e9en Georges Pompidou, service d'h\u00e9matologie biologique et laboratoire de recherches biochirurgicales (fondation Carpentier), 75015 Paris, France. Electronic address: nicolas.gendron@aphp.fr","H\u00f4pital Europ\u00e9en Georges Pompidou [APHP]","Innovations th\u00e9rapeutiques en h\u00e9mostase = Innovative Therapies in Haemostasis","Universit\u00e9 Paris Cit\u00e9"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 de Paris, Innovative Therapies in Haemostasis, Inserm, 75006 Paris, France; AH-HP, H\u00f4pital europ\u00e9en Georges Pompidou, service d'h\u00e9matologie biologique et laboratoire de recherches biochirurgicales (fondation Carpentier), 75015 Paris, France. Electronic address: nicolas.gendron@aphp.fr","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210102325","https://openalex.org/I4387152685"]},{"raw_affiliation_string":"H\u00f4pital Europ\u00e9en Georges Pompidou [APHP]","institution_ids":["https://openalex.org/I4210102325"]},{"raw_affiliation_string":"Innovations th\u00e9rapeutiques en h\u00e9mostase = Innovative Therapies in Haemostasis","institution_ids":["https://openalex.org/I4387152685"]},{"raw_affiliation_string":"Universit\u00e9 Paris Cit\u00e9","institution_ids":["https://openalex.org/I204730241"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5136608968"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210102325","https://openalex.org/I4387152685"],"apc_list":{"value":1685,"currency":"USD","value_usd":1685},"apc_paid":{"value":1685,"currency":"USD","value_usd":1685},"fwci":0.0411,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.06630824,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"107","issue":"5","first_page":"574","last_page":"585"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.9829999804496765},{"id":"https://openalex.org/keywords/venous-thromboembolism","display_name":"venous thromboembolism","score":0.843999981880188},{"id":"https://openalex.org/keywords/cancer-associated-thrombosis","display_name":"cancer-associated thrombosis","score":0.9409999847412109},{"id":"https://openalex.org/keywords/low-molecular-weight-heparin","display_name":"low molecular weight heparin","score":0.8399999737739563},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.6200000047683716},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.6579999923706055},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9350000023841858},{"id":"https://openalex.org/keywords/cytochrome-p450","display_name":"cytochrome P450","score":0.949999988079071},{"id":"https://openalex.org/keywords/personalized-anticoagulation","display_name":"personalized anticoagulation","score":0.7139999866485596},{"id":"https://openalex.org/keywords/urogenital-cancer","display_name":"urogenital cancer","score":0.9629999995231628},{"id":"https://openalex.org/keywords/thromboprophylaxis","display_name":"thromboprophylaxis","score":0.6790000200271606}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7971757650375366},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.533053994178772}],"mesh":[{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000069604","descriptor_name":"Dabigatran","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000069604","descriptor_name":"Dabigatran","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000070997","descriptor_name":"ATP Binding Cassette Transporter, Subfamily G, Member 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006495","descriptor_name":"Heparin, Low-Molecular-Weight","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013927","descriptor_name":"Thrombosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013927","descriptor_name":"Thrombosis","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D018435","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D054556","descriptor_name":"Venous Thromboembolism","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D055502","descriptor_name":"Secondary Prevention","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.bulcan.2020.02.010","doi":"https://doi.org/10.1016/j.bulcan.2020.02.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bulcan.2020.02.010","pdf_url":"https://www.sciencedirect.com/science/article/am/pii/S0007455120301466","source":{"id":"https://openalex.org/S22998730","display_name":"Bulletin du Cancer","issn_l":"0007-4551","issn":["0007-4551","1769-6917"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Bulletin du Cancer","raw_type":"journal-article"},{"id":"pmid:32252973","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32252973","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bulletin du cancer","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-03490406v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-03490406","pdf_url":"https://hal.science/hal-03490406v1/document","source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Bulletin du Cancer, 2020, 107, pp.574 - 585. &#x27E8;10.1016/j.bulcan.2020.02.010&#x27E9;","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1016/j.bulcan.2020.02.010","doi":"https://doi.org/10.1016/j.bulcan.2020.02.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bulcan.2020.02.010","pdf_url":"https://www.sciencedirect.com/science/article/am/pii/S0007455120301466","source":{"id":"https://openalex.org/S22998730","display_name":"Bulletin du Cancer","issn_l":"0007-4551","issn":["0007-4551","1769-6917"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Bulletin du Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3014291483.pdf","grobid_xml":"https://content.openalex.org/works/W3014291483.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W1517107864","https://openalex.org/W1564607482","https://openalex.org/W2075341962","https://openalex.org/W2083713858","https://openalex.org/W2096246254","https://openalex.org/W2138426988","https://openalex.org/W2164084739","https://openalex.org/W2516544744","https://openalex.org/W2548586504","https://openalex.org/W2559528249","https://openalex.org/W2608749797","https://openalex.org/W2730172418","https://openalex.org/W2764121201","https://openalex.org/W2769760280","https://openalex.org/W2792485334","https://openalex.org/W2792857103","https://openalex.org/W2794395525","https://openalex.org/W2802130786","https://openalex.org/W2803510758","https://openalex.org/W2810860675","https://openalex.org/W2846048063","https://openalex.org/W2884379119","https://openalex.org/W2885394836","https://openalex.org/W2893649877","https://openalex.org/W2901202385","https://openalex.org/W2902078827","https://openalex.org/W2966354200","https://openalex.org/W2972019042","https://openalex.org/W2981923069","https://openalex.org/W2986829758","https://openalex.org/W7225829785"],"related_works":["https://openalex.org/W3003649446","https://openalex.org/W2792243825","https://openalex.org/W2887538206","https://openalex.org/W3176472369","https://openalex.org/W3042838320","https://openalex.org/W3122053149","https://openalex.org/W2280555850","https://openalex.org/W2038619229","https://openalex.org/W4292410292","https://openalex.org/W4311023225"],"abstract_inverted_index":{"Les":[0,69,137],"anticoagulants":[1,50,70,123,146,265,291,308,341,358],"oraux":[2,51,71,124,147],"directs,":[3],"anti-IIa":[4,241],"ou":[5,170,233],"anti-Xa,":[6,243],"sont":[7,30,53],"largement":[8],"utilis\u00e9s":[9],"dans":[10,23,81,126,149,201],"le":[11,79,82,103,127,218,224],"traitement":[12,83,104,128],"et":[13,37,222],"la":[14,17,24,57,85,93,130,150,177,188,208],"pr\u00e9vention":[15,151],"de":[16,56,59,63,76,84,97,105,111,118,129,139,167,187,196,204,207,220,236],"maladie":[18,86,131,209],"thromboembolique":[19,87,132,210],"veineuse":[20,88,133,211],"ainsi":[21],"que":[22],"fibrillation":[25],"atriale":[26],"non":[27],"valvulaire.":[28],"Ils":[29],"caract\u00e9ris\u00e9s":[31],"par":[32],"une":[33,143,202],"action":[34],"rapide,":[35],"pr\u00e9visible":[36],"un":[38],"intervalle":[39],"th\u00e9rapeutique":[40,192,205],"large.":[41],"N\u00e9anmoins,":[42,110],"des":[43,54,66,95,145,152,179,193],"interactions":[44,286,424],"m\u00e9dicamenteuses":[45,228],"th\u00e9oriques":[46],"existent":[47],"puisque":[48],"les":[49,116,164,173,182,230,234],"directs":[52,72,125,148],"substrats":[55],"prot\u00e9ine":[58],"transport":[60,296],"P-glycoprot\u00e9ine":[61],"et/ou":[62],"certains":[64],"isoformes":[65],"cytochromes":[67,303],"P450.":[68],"n\u2019ont":[73],"pas":[74],"d\u2019autorisation":[75],"mise":[77],"sur":[78],"march\u00e9":[80],"associ\u00e9e":[89,134,212],"au":[90,135,157,213],"cancer":[91,214,221,400,415],"\u00e0":[92,107,176],"diff\u00e9rence":[94,178],"h\u00e9parines":[96,117],"bas":[98,119],"poids":[99,120],"mol\u00e9culaire":[100,121],"qui":[101],"restent":[102],"r\u00e9f\u00e9rence":[106],"ce":[108],"jour.":[109],"r\u00e9centes":[112],"\u00e9tudes":[113,141],"ont":[114],"compar\u00e9":[115],"aux":[122],"cancer.":[136],"r\u00e9sultats":[138],"ces":[140],"sugg\u00e8rent":[142],"non-inf\u00e9riorit\u00e9":[144],"r\u00e9cidives":[153],"d\u2019\u00e9v\u00e9nements":[154],"thromboemboliques":[155],"mais":[156],"prix":[158],"d\u2019un":[159],"sur-risque":[160],"h\u00e9morragique,":[161],"notamment":[162],"pour":[163],"patients":[165,194,378],"atteints":[166,195],"cancers":[168],"gastro-intestinaux":[169],"urog\u00e9nitaux.":[171],"Ainsi,":[172],"recommandations":[174,180],"internationales,":[175],"fran\u00e7aises,":[181],"int\u00e8grent":[183],"en":[184,190,216],"premi\u00e8re":[185],"ligne":[186],"prise":[189],"charge":[191],"cancers.":[197,383],"Nous":[198],"rentrons":[199],"certainement":[200],"aire":[203],"personnalis\u00e9e":[206],"prenant":[215],"compte":[217],"type":[219,416],"\u00e9galement":[223],"risque":[225],"th\u00e9orique":[226],"d\u2019interactions":[227],"avec":[229],"traitements":[231],"anti-canc\u00e9reux":[232],"soins":[235],"support.":[237],"Direct":[238,263,306],"oral":[239,264,290,307,340,357],"anticoagulants,":[240],"or":[242,428],"are":[244,266,292,403],"widely":[245],"used":[246],"in":[247,259,342,359,375,392],"the":[248,295,316,326,343,360,368,396,419],"treatment":[249,317,329,344],"and":[250,277,381,417],"prevention":[251,361],"of":[252,272,294,300,302,318,345,349,355,362,370,395,399,408,422],"venous":[253],"thromboembolic":[254,364],"disease":[255],"as":[256,258],"well":[257],"nonvalvular":[260],"atrial":[261],"fibrillation.":[262],"characterized":[267],"by":[268],"a":[269,274,278,312,353],"rapid":[270],"onset":[271],"activity,":[273],"predictable":[275],"response":[276],"relatively":[279],"wide":[280],"therapeutic":[281,397],"window.":[282],"Nevertheless,":[283],"theoretical":[284,420],"drug":[285,423],"exist":[287],"since":[288],"direct":[289,339,356],"substrates":[293],"protein":[297],"P-glycoprotein":[298],"and/or":[299],"isoforms":[301],"P450":[304],"pathway.":[305],"do":[309],"not":[310],"have":[311,334],"marketing":[313],"authorization":[314],"for":[315,377,411],"cancer-associated":[319,346,412],"thrombosis":[320],"unlike":[321,387],"low-molecular-weight":[322,336],"heparins":[323,337],"which":[324],"remain":[325],"gold":[327],"standard":[328],"today.":[330],"However,":[331],"recent":[332],"studies":[333,351],"compared":[335],"to":[338],"thrombosis.":[347],"Results":[348],"these":[350],"showed":[352],"non-inferiority":[354],"recurrent":[363],"events":[365],"but":[366],"at":[367],"cost":[369],"an":[371,406],"increased":[372],"hemorrhagic":[373],"risk,":[374],"particular":[376],"with":[379,425],"gastrointestinal":[380],"urogenital":[382],"Thus,":[384],"international":[385],"guidelines,":[386,389],"French":[388],"integrate":[390],"them":[391],"first":[393],"line":[394],"strategy":[398],"patients.":[401],"We":[402],"certainly":[404],"entering":[405],"era":[407],"personalized":[409],"therapy":[410],"thrombosis,":[413],"considering":[414],"also":[418],"risk":[421],"anti-cancer":[426],"treatments":[427],"supportive":[429],"care.":[430]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3014291483","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2020-04-10T00:00:00"}
